Divis Laboratories Ltd (DIVISLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 509760, "name": "Divi's Lab.", "stock_name": "Divi's Lab.", "full_name": "Divis Laboratories Ltd", "name_url": "stocks-analysis/divi-s-lab", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "6,007.00", "chg": -137.8, "chgp": "-2.24%", "dir": -1, "prev_price": "6,144.80", "mcapval": "160,662.00 Cr", "mcap": "Large Cap", "scripcode": 532488, "symbol": "DIVISLAB", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE361B01024", "curr_date": "Mar 19", "curr_time": "", "bse_nse_vol": "1.27 lacs", "exc_status": "Active", "traded_date": "Mar 19, 2026", "traded_date_str": "2026 03 19", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Divis Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-sell-3898448", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_mojoScore_3898448.png", "date": "2026-03-18 10:10:49", "description": "Divis Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 March 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing." }, { "title": "Divis Laboratories Ltd Faces Bearish Momentum Amid Technical Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-faces-bearish-momentum-amid-technical-downgrade-3892657", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_technicaldot_3892657.png", "date": "2026-03-16 08:01:12", "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Hold to a Sell rating reflects deteriorating technical conditions, underscored by weakening moving averages and bearish momentum oscillators." }, { "title": "Divis Laboratories Ltd Hits Intraday Low Amid Price Pressure on 13 Mar 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-hits-intraday-low-amid-price-pressure-on-13-mar-2026-3889974", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_priceRelatedfactors_3889974.png", "date": "2026-03-13 19:01:08", "description": "Divis Laboratories Ltd experienced a notable intraday decline on 13 Mar 2026, touching a low of Rs 6,051.8, reflecting a 3.58% drop from previous levels. The stock underperformed its sector and broader market indices amid widespread selling pressure, continuing a three-day downward trend." }, { "title": "Divis Laboratories Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-sell-3877819", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/DivisLaboratori_mojoScore_3877819.png", "date": "2026-03-07 10:10:38", "description": "Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 07 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Divis Laboratories Gains 1.92%: 3 Key Technical and Market Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-gains-192-3-key-technical-and-market-factors-driving-the-week-3862608", "imagepath": "", "date": "2026-02-28 16:05:32", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Feb:</strong> Stock opened at Rs.6,294.70 with marginal gains despite Sensex rally</p>\n <p><strong>24 Feb:</strong> Price dipped 0.63% amid broader market weakness</p>\n <p><strong>25 Feb:</strong> Bearish technical shift noted; stock rebounded 2.29%</p>\n <p><strong>26 Feb:</strong> Sharp open interest surge and 1.13% price gain</p>\n <p><strong>27 Feb:</strong> Week closed at Rs.6,412.70, down 0.89% on weak market day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6,291.95</di..." }, { "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Rising Market Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-rising-market-momentum-3858304", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DivisLaboratori_oi_spurts_by_underlying_3858304.png", "date": "2026-02-26 15:00:07", "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling heightened market participation and evolving positioning among investors. This development comes alongside a steady price appreciation and increased trading volumes, reflecting a complex interplay of bullish and cautious sentiments in the stock." }, { "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Rising Market Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-rising-market-momentum-3858254", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DivisLaboratori_oi_spurts_by_underlying_3858254.png", "date": "2026-02-26 14:00:06", "description": "Divis Laboratories Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical giant’s stock has concurrently shown steady gains, supported by robust volume and delivery trends, suggesting a potential directional bias emerging among traders." }, { "title": "Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3857264", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DivisLaboratori_technicaldot_3857264.png", "date": "2026-02-26 08:01:07", "description": "Divis Laboratories Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish indicators. Despite a recent upgrade in price momentum from bearish to mildly bearish, the stock’s technical landscape remains mixed, with key indicators such as MACD, RSI, and moving averages signalling caution for investors navigating the Pharmaceuticals & Biotechnology sector." }, { "title": "Divis Laboratories Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-faces-bearish-technical-shift-amid-mixed-momentum-signals-3854650", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/DivisLaboratori_technicaldot_3854650.png", "date": "2026-02-25 08:01:44", "description": "Divis Laboratories Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with several indicators signalling a bearish trend. Despite a strong long-term performance relative to the Sensex, recent technical parameters suggest caution for investors as the stock navigates a challenging phase." } ], "total": 593, "sid": "509760", "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "14-Mar-2026", "details": "Newspaper clippings - Special Window for transfer and dematerialisation of physical shares.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "14-Feb-2026", "details": "Submission of transcript of Earnings Conference Call held on February 11 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "12-Feb-2026", "details": "As enclosed", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25", "dt": "2025-07-25", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07", "dt": "2007-08-03", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15", "dt": "2015-09-23", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

23 Feb: Stock opened at Rs.6,294.70 with marginal gains despite Sensex rally

24 Feb: Price dipped 0.63% amid broader market weakness

25 Feb: Bearish technical shift noted; stock rebounded 2.29%

26 Feb: Sharp open interest surge and 1.13% price gain

27 Feb: Week closed at Rs.6,412.70, down 0.89% on weak market day

Week Open

Rs.6,291.95Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Rising Market Momentum

2026-02-26 15:00:07

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling heightened market participation and evolving positioning among investors. This development comes alongside a steady price appreciation and increased trading volumes, reflecting a complex interplay of bullish and cautious sentiments in the stock.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Rising Market Momentum

2026-02-26 14:00:06

Divis Laboratories Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. The pharmaceutical giant’s stock has concurrently shown steady gains, supported by robust volume and delivery trends, suggesting a potential directional bias emerging among traders.

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-02-26 08:01:07

Divis Laboratories Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish indicators. Despite a recent upgrade in price momentum from bearish to mildly bearish, the stock’s technical landscape remains mixed, with key indicators such as MACD, RSI, and moving averages signalling caution for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Divis Laboratories Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals

2026-02-25 08:01:44

Divis Laboratories Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with several indicators signalling a bearish trend. Despite a strong long-term performance relative to the Sensex, recent technical parameters suggest caution for investors as the stock navigates a challenging phase.

Read full news article